Shaping the Future of Treating Deep Venous Disease

The Vesper DUO Venous Stent System® is designed to be the next generation venous stent portfolio uniquely engineered to address the multiple anatomical challenges of the deep venous system for the broad range of patients with Chronic Venous Insufficiency (CVI).

The VIVID Clinical Trial is currently recruiting adult patients that have CVI and are eligible for a venous stent in their iliac or common femoral veins.

Our Stent Portfolio VIVID Trial Details

Vesper Medical in the news

Vesper Medical Announces $37 Million Financing with Vensana Capital and Gilde Healthcare to Complete Development of its Duo Venous Stent System™ Read More >

Dr. Mark Garcia Joins Vesper Medical as Chief Medical Officer Read More >

Vesper Medical Completes $10.5 M Series of Financing to Drive Development of Next Generation Venous Stents Read More >

Vesper Medical Logo

Contact us for information about Vesper Medical and the VIVID clinical study

* Required Field

Scroll to Top